Fibrinolytic Agents

Displaying 1 - 5 of 5CSV
Shu, L., Akpokiere, F., Mandel, D. M., Field, T. S., Leon Guerrero, C. R., Henninger, N., Muppa, J., Affan, M., Haq Lodhi, O. U., Heldner, M. R., Antonenko, K., Seiffge, D. J., Arnold, M., Salehi Omran, S., Crandall, R., Lester, E., López-Mena, D., Arauz, A., Nehme, A., … Yaghi, S. (2024). Intravenous Thrombolysis in Patients With Cervical Artery Dissection. Neurology, 103(7). https://doi.org/10.1212/wnl.0000000000209843
Publication Date
Ebrahimi, P., Sattartabar, B., Taheri, H., Soltani, P., Bahiraie, P., Mousavinezhad, S. M., Gooshvar, M., Kampaktsis, P. N., Arsanjani, R., Sahebjam, M., Hosseini, K., & Siegel, R. J. (2024). Mechanical prosthetic valve thrombosis: A literature review of treatment strategies. Current Problems in Cardiology, 49(7), 102628. https://doi.org/10.1016/j.cpcardiol.2024.102628
Publication Date
Talasaz, A. H., Sadeghipour, P., Ortega-Paz, L., Kakavand, H., Aghakouchakzadeh, M., Beavers, C., Fanikos, J., Eikelboom, J. W., Siegal, D. M., Monreal, M., Jimenez, D., Vaduganathan, M., Castellucci, L. A., Cuker, A., Barnes, G. D., Connors, J. M., Secemsky, E. A., Van Tassell, B. W., De Caterina, R., … Bikdeli, B. (2024). Optimizing antithrombotic therapy in patients with coexisting cardiovascular and gastrointestinal disease. Nature Reviews Cardiology, 21(8), 574–592. https://doi.org/10.1038/s41569-024-01003-3
Publication Date
Rashedi, S., Greason, C. M., Sadeghipour, P., Talasaz, A. H., O’Donoghue, M. L., Jimenez, D., Monreal, M., Anderson, C. D., Elkind, M. S. V., Kreuziger, L. M. B., Lang, I. M., Goldhaber, S. Z., Konstantinides, S. V., Piazza, G., Krumholz, H. M., Braunwald, E., & Bikdeli, B. (2024). Fibrinolytic Agents in Thromboembolic Diseases: Historical Perspectives and Approved Indications. Seminars in Thrombosis and Hemostasis, 50(05), 773–789. CLOCKSS. https://doi.org/10.1055/s-0044-1781451
Publication Date
Witsch, J., Roh, D. J., Avadhani, R., Merkler, A. E., Kamel, H., Awad, I., Hanley, D. F., Ziai, W. C., & Murthy, S. B. (2021). Association Between Intraventricular Alteplase Use and Parenchymal Hematoma Volume in Patients With Spontaneous Intracerebral Hemorrhage and Intraventricular Hemorrhage. JAMA Network Open, 4(12), e2135773. https://doi.org/10.1001/jamanetworkopen.2021.35773
Publication Date